| 000 | 01387 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512074321.0 | ||
| 264 | 0 | _c19860102 | |
| 008 | 198601s 0 0 eng d | ||
| 022 | _a0340-7004 | ||
| 024 | 7 |
_a10.1007/BF00205574 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFavalli, C | |
| 245 | 0 | 0 |
_aModulation of natural killer activity by thymosin alpha 1 and interferon. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _c1985 |
||
| 300 |
_a189-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCyclophosphamide _xpharmacology |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aImmunity, Innate _xdrug effects |
| 650 | 0 | 4 |
_aInterferon Type I _ximmunology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aRadiation Chimera |
| 650 | 0 | 4 | _aThymalfasin |
| 650 | 0 | 4 |
_aThymosin _xanalogs & derivatives |
| 700 | 1 | _aJezzi, T | |
| 700 | 1 | _aMastino, A | |
| 700 | 1 | _aRinaldi-Garaci, C | |
| 700 | 1 | _aRiccardi, C | |
| 700 | 1 | _aGaraci, E | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 20 _gno. 3 _gp. 189-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00205574 _zAvailable from publisher's website |
| 999 |
_c3857389 _d3857389 |
||